Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
15
|
pubmed:dateCreated |
1997-10-3
|
pubmed:databankReference | |
pubmed:abstractText |
Repeated doses of cocaine or amphetamine lead to long-lasting behavioral manifestations that include enhanced responses termed sensitization. Although biochemical mechanisms that underlie these manifestations currently remain largely unknown, new protein synthesis has been implicated in several of these neuroadaptive processes. To seek candidate biochemical mechanisms for these drug-induced neuroplastic behavioral responses, we have used an approach termed subtracted differential display (SDD) to identify genes whose expression is regulated by these psychostimulants. rGbeta1 is one of the SDD products that encodes a rat G-protein beta subunit. rGbeta1 expression is upregulated by cocaine or amphetamine treatments in neurons of the nucleus accumbens shell region, a major center for psychostimulant effects in locomotor control and behavioral reward. Antisense oligonucleotide treatments that attenuate rGbeta1 expression in regions including the nucleus accumbens abolish the development of behavioral sensitization when they are administrated during the repeated cocaine exposures that establish sensitization. These treatments fail to alter acute behavioral responses to cocaine, and they do not block the expression of cocaine sensitization when it is established before oligonucleotide administrations. Full, regulated rGbeta1 expression is a biochemical component essential to the establishment of a key consequence of repeated cocaine administrations, sensitization.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0270-6474
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5993-6000
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9221795-Amino Acid Sequence,
pubmed-meshheading:9221795-Animals,
pubmed-meshheading:9221795-Base Sequence,
pubmed-meshheading:9221795-Cocaine,
pubmed-meshheading:9221795-Corpus Striatum,
pubmed-meshheading:9221795-GTP-Binding Proteins,
pubmed-meshheading:9221795-Gene Expression,
pubmed-meshheading:9221795-Locomotion,
pubmed-meshheading:9221795-Male,
pubmed-meshheading:9221795-Molecular Sequence Data,
pubmed-meshheading:9221795-Rats,
pubmed-meshheading:9221795-Rats, Sprague-Dawley,
pubmed-meshheading:9221795-Sensitivity and Specificity
|
pubmed:year |
1997
|
pubmed:articleTitle |
rGbeta1: a psychostimulant-regulated gene essential for establishing cocaine sensitization.
|
pubmed:affiliation |
Molecular Neurobiology Branch, Intramural Research Program, National Institute on Drug Abuse, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|